Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies
Year: 2020
Type: editorial
Abstract: An update of the chapter on Mental, Behavioral and Neurodevelopmental Disorders in the International Classification of Diseases and Related Health Problems (ICD) is of great interest around the world. The recent approval of the 11th Revision of the ICD (ICD-11) by the World Health Organization (WHO) raises broad questions about the status of nosology of mental disorders as a whole as well as more focused questions regarding changes to the diagnostic guidelines for specific conditions and the implications of these changes for practice and research. This Forum brings together a broad range of experts to reflect on key changes and controversies in the ICD-11 classification of mental disorders. Taken together, there is consensus that the WHO's focus on global applicability and clinical utility in developing the diagnostic guidelines for this chapter will maximize the likelihood that it will be adopted by mental health professionals and administrators. This focus is also expected to enhance the application of the guidelines in non-specialist settings and their usefulness for scaling up evidence-based interventions. The new mental disorders classification in ICD-11 and its accompanying diagnostic guidelines therefore represent an important, albeit iterative, advance for the field.
Source: BMC Medicine
Institutions: South African Medical Research Council, University of Cape Town, Centre for Addiction and Mental Health, University of Toronto, Hospital for Sick Children, Heinrich Heine University Düsseldorf, Barwon Health, Deakin University, The University of Melbourne, Florey Institute of Neuroscience and Mental Health, Orygen, Centro de Investigación Biomédica en Red de Salud Mental, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, University of Campania "Luigi Vanvitelli", University of Groningen, University of Zurich, University College London, Columbia University, Yale University, University of Hertfordshire, Hertfordshire Partnership University NHS Foundation Trust, University Medical Center Hamburg-Eppendorf, Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, Columbia University Irving Medical Center, World Health Organization
Language: English
Topic: Mental Health and Psychiatry
Subfield: Philosophy
Field: Arts and Humanities
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,490
Funders: Pfizer, Sanofi, World Health Organization, Sunovion, Royal College of Psychiatrists, Ministerio de Ciencia, Innovación y Universidades, Centres de Recerca de Catalunya, National Institute for Health and Care Research, University of Oxford, Beyond Blue, South African Medical Research Council, Generalitat de Catalunya, Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya, Dainippon Sumitomo Pharma, Centro de Investigación Biomédica en Red de Salud Mental, European College of Neuropsychopharmacology, Servier, H. Lundbeck A/S, National Institutes of Health, Allergan, Medical Research Council, National Health and Medical Research Council, Instituto de Salud Carlos III, European Regional Development Fund, National Center for Advancing Translational Sciences
Awards: G109340971, Implicación de variantes del gen DDR1 en la integridad de la mielina y en la velocidad de procesamiento cognitivo en pacientes con trastorno bipolar en fase eutímica, G1552314173, G1935761306, G2059268795, G2580371796, G3108940385, G3288897321, G3643768411, Novel therapies for psychiatric disorders, G5824764493, G68579704, G698350584, G7319140253, G7934779123, Novel therapies, risk pathways and prevention of mood disorders, Yale Clinical and Translational Science Award
OpenAlex ID: W3003406382